Clinical guidelines universally recommend active surveillance—monitoring with curative intent—for indolent-grade group(GG)1 prostate cancer(PCa).Moreover,a growing body of literature supports reclassifying GG 1 as“...Clinical guidelines universally recommend active surveillance—monitoring with curative intent—for indolent-grade group(GG)1 prostate cancer(PCa).Moreover,a growing body of literature supports reclassifying GG 1 as“non-cancer.”^([1])However,PCa is often multifocal,and a biopsy may be performed for diagnosis.To assess potential biopsy undersampling,we characterized upgrading and upstaging at radical prostatectomy(RP)among males initially diagnosed with GG1 disease using data from 2 large cohorts:Sur-veillance,Epidemiology,and End Results(SEER)and the National Cancer Database(NCDB).展开更多
文摘Clinical guidelines universally recommend active surveillance—monitoring with curative intent—for indolent-grade group(GG)1 prostate cancer(PCa).Moreover,a growing body of literature supports reclassifying GG 1 as“non-cancer.”^([1])However,PCa is often multifocal,and a biopsy may be performed for diagnosis.To assess potential biopsy undersampling,we characterized upgrading and upstaging at radical prostatectomy(RP)among males initially diagnosed with GG1 disease using data from 2 large cohorts:Sur-veillance,Epidemiology,and End Results(SEER)and the National Cancer Database(NCDB).
